Fig. 6From: Development and validation of an individualized gene expression-based signature to predict overall survival of patients with high-grade serous ovarian carcinomaThe relationship between risk score and prognosis in the GSE26712 set. A The relationship between 2-gene signature and survival status, survival duration, and expression in the GSE26712 set. B ROC and AUC of 2-gene signature in GSE26712 set. C KM survival curve of 2-gene signature in GSE26712 setBack to article page